Drug
VeraCept
VeraCept is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
150%(3 trials)
Phase Distribution
Ph phase_3
2
67%
Ph phase_2
1
33%
Phase Distribution
0
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 3Large-scale testing
2(66.7%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 21 (33.3%)
Phase 32 (66.7%)
Trials by Status
active_not_recruiting133%
completed267%
Recent Activity
1 active trials
Showing 3 of 3
completedphase_2
Evaluation of ContraMed VeraCept Intrauterine Copper Contraceptive for Long Acting Reversible Contraception
NCT02446821
active_not_recruitingphase_3
Evaluation of Efficacy, Safety and Tolerability of VeraCept IUS
NCT03633799
completedphase_3
A PK Study Comparing VeraCept vs. ParaGard Intrauterine Devices (IUDs)
NCT03785366
Clinical Trials (3)
Showing 3 of 3 trials
NCT02446821Phase 2
Evaluation of ContraMed VeraCept Intrauterine Copper Contraceptive for Long Acting Reversible Contraception
NCT03633799Phase 3
Evaluation of Efficacy, Safety and Tolerability of VeraCept IUS
NCT03785366Phase 3
A PK Study Comparing VeraCept vs. ParaGard Intrauterine Devices (IUDs)
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3